Revolutionary Cell Transplant for Ovarian Cancer
Krupa CompaniesEffort to Enhance the Effectiveness of Chemotherapy for Persistent Ovarian Cancer lead by Robert A. Bayer, MD, from the Loyola University Medical Center, Cardinal Bernardin Cancer Center. Study of 100 Women Reveals That Patients with High Dose Chemotherapy with a Bone Marrow or Blood Cell Transplant May Respond Best to Drug Treatments.